FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to an antibody for treating or preventing an infectious disease caused by the O25b antigen. Also disclosed are a pharmaceutical preparation and a diagnostic preparation containing said antibody. Disclosed is a candidate antibody identification method, use of said antibody for prevention and diagnosis.
EFFECT: invention has the ability effectively treat diseases caused by O25b antigen.
10 cl, 4 ex, 1 tbl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT ANTIBODY, PLASMID, EXPRESSION CASSETTE, HOST CELL, METHOD OF PRODUCING SAID ANTIBODY (EMBODIMENTS), METHOD OF IDENTIFYING CANDIDATE ANTIBODY, COMPOSITION AND IMMUNOGEN | 2014 |
|
RU2819254C1 |
| RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS | 2014 |
|
RU2724530C2 |
| HUMANIZED TAU-ANTIBODY | 2013 |
|
RU2644242C2 |
| MONOCLONAL ANTIBODIES AND METHODS FOR THEIR APPLICATION | 2012 |
|
RU2623122C2 |
| ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF | 2012 |
|
RU2658603C2 |
| ANTIBODIES SPECIFIC TO CLAUDIN 6 (CLDN6) | 2010 |
|
RU2675997C2 |
| ANTIBODIES USEFUL IN DIAGNOSING CANCER | 2018 |
|
RU2815883C1 |
| MONOCLONAL ANTI-CLAUDIN-18 ANTIBODIES FOR TREATING CANCER | 2008 |
|
RU2571923C2 |
| BIVALENT BISPECIFIC ANTIBODIES | 2008 |
|
RU2587616C2 |
| CANCER TREATMENT USING TARGETED ANTIBODIES IN VIVO | 2011 |
|
RU2642305C2 |
